About Sermorelin Script

What this site is

Sermorelin Script reads the peer-reviewed research on sermorelin (GHRH(1-29)) as an annotated transcript — a careful line-by-line rendering of what the studies report, with the source kept in view. It is a reading of the record, not a service that acts on it. Nobody here runs a clinic or answers as a clinician; no medical advice is given, and nothing is compounded, prescribed, made, or sold. What the site produces is a transcript with citations, not a product or a course of treatment.

The approach is deliberately narrow and deliberately sourced. We read the GHRH-receptor pharmacology, the dose-response data, and the open questions, and we carry every quantitative claim back to a study you can verify. The site is built to be read like an instrument panel: a quiet, signal-first reading of what the literature measured, with the citations always in view.

About the name

The word "script" in this site's name is editorial framing, not a service claim. It signals that the site reads the published record as a protocol digest — a careful transcription of what the studies report — and nothing more. There is no prescription pad behind the name, no pharmacy, and no storefront. "Script" here means the written record, the score the instrument plays from; it does not mean we write, fill, or facilitate any prescription, and it does not imply we offer treatment, consultation, or dispensing of any kind.

How we handle the evidence

Three editorial commitments govern the content. First, we separate what was measured from what is marketed: where adult anti-aging or body-composition claims rest on a related analog such as tesamorelin rather than on sermorelin itself, we say so. Second, we state the regulatory history accurately — sermorelin was FDA-approved for pediatric GH deficiency and withdrawn from the US market in 2008 for commercial reasons, and is now compounded; we describe it as formerly approved and presently compounded, rather than as a currently marketed drug or one that was never sanctioned. Third, we use research framing throughout: studied doses are reported as "studied at X in [population]," never as instructions, because the material describes laboratory research, not a course of treatment.